Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1

Abstract

Ultrasound-targeted microbubble destruction (UTMD) was used to direct betacellulin (BTC) and pancreatic duodenal homeobox-1 (PDX1) to rat pancreas 48 h after islet destruction by streptozotocin (STZ). Sprague–Dawley rats were rendered diabetic by STZ injection. Controls included normal rats, STZ only without UTMD, and UTMD with DsRed reporter gene. Blood glucose increased dramatically in all rats 48 h after STZ, and continued to rise after UTMD with BTC alone. Blood glucose declined from day 3 to day 10 after UTMD with PDX1, but remained elevated (261±8 mg/dl). However, in rats treated with both BTC and PDX1, blood glucose remained below 200 mg/dl throughout day 10. This was accompanied by normalization of blood insulin and C-peptide. Histology demonstrated islet-like clusters of glucagon-staining cells in the rats treated with BTC and PDX1, but these clusters disappeared by 30 days after UTMD treatment. Although regeneration of insulin-producing islets was not seen, diabetes was reversed for up to 15 days after a single UTMD treatment by ectopic insulin production by pancreatic acinar cells. These cells co-expressed amylase and insulin and demonstrated several β-cell markers by reverse transcription-PCR. Gene therapy by UTMD can reverse diabetes in vivo in adult rats by restoring pancreatic insulin production.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–1053.

    Article  Google Scholar 

  2. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005; 28: 2130–2135.

    Article  Google Scholar 

  3. Bonner-Weir S, Wier GC . New sources of pancreatic β-cells. Nat Biotechnol 2005; 23: 857–861.

    Article  CAS  Google Scholar 

  4. Samson S, Chan L . Gene therapy for diabetes: reinventing the islet. Trends Endocrinol Metab 2005; 17: 92–100.

    Article  Google Scholar 

  5. Lipsett M, Aikin R, Castellarin M, Hanley S, Jamal A, Laganiere S et al. Islet neogenesis: a potential therapeutic tool in type 1 diabetes. Int J Biochem Cell Biol 2006; 38: 498–503.

    Article  CAS  Google Scholar 

  6. Chen S, Ding JH, Bekeredjian R, Yang BZ, Shohet RV, Johnston SA et al. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci USA 2006; 103: 8469–8474.

    Article  CAS  Google Scholar 

  7. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.

    Article  Google Scholar 

  8. The EDIC Study Group. Sustained effect of intensive treatment in type I diabetes mellitus on development and progression of diabetic retinopathy: the epidemiology of diabetes interventions and complications (EDIC) study. JAMA 2003; 290: 2159–2167.

    Article  Google Scholar 

  9. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE . A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 1993; 42: 1715–1720.

    Article  CAS  Google Scholar 

  10. Guz Y, Nasir I, Teitelman G . Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology 2001; 142: 4956–4968.

    Article  CAS  Google Scholar 

  11. Sarvetnick NE, Gu D . Regeneration of pancreatic endocrine cells in interferon-gamma transgenic mice. Adv Exp Med Biol 1992; 321: 85–89.

    Article  CAS  Google Scholar 

  12. Dor Y, Brown J, Martinez OI, Melton DA . Adult pancreatic beta-cells are formed by self-duplication rather than stem cell differentiation. Nature 2004; 429: 41–46.

    Article  CAS  Google Scholar 

  13. Hao E, Tyrberg B, Itkin-Ansari P, Lakey J, Geron I, Monosov EZ et al. Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med 2006; 12: 310–316.

    Article  CAS  Google Scholar 

  14. Zhan Y, Brady JL, Johnston AM, Lew AM . Predominate transgene expression in exocrine pancreas directed by the CMV promoter. DNA Cell Biol 2000; 19: 639–645.

    Article  CAS  Google Scholar 

  15. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000; 6: 568–572.

    Article  CAS  Google Scholar 

  16. Shing Y, Christofori G, Hanahan D, Ono Y, Sasada R, Igarashi K et al. Betacellulin: a mitogen from pancreatic beta cell tumors. Science 1993; 259: 2681–2689.

    Article  Google Scholar 

  17. Kojima H, Nakamura T, Fujita Y, Kishi A, Fujimiya M, Yamada S et al. Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes 2002; 51: 1398–1408.

    Article  CAS  Google Scholar 

  18. Kojima H, Fujimaya M, Matsumura K, Younan P, Imaeda H, Maeda M et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 2003; 9: 596–603.

    Article  CAS  Google Scholar 

  19. Tada H, Sasada R, Kawaguchi Y, Kojima I, Gullick WJ, Salomon DS et al. Processing and juxtacrine activity of membrane-anchored betacellulin. J Cell Biochem 1999; 72: 423–434.

    Article  CAS  Google Scholar 

  20. Gelling RW, Du XQ, Dichmann DS, Romer J, Huang H, Cui L et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA 2003; 100: 1438–1443.

    Article  CAS  Google Scholar 

  21. Lardon J, Huyens N, Rooman I, Bouwens L . Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas. Virchows Arch 2004; 444: 61–65.

    Article  Google Scholar 

  22. Baeyens L, De Breuck S, Lardon J, Mfopou JK, Rooman I, Bouwens L . In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 2005; 48: 49–57.

    Article  CAS  Google Scholar 

  23. Rooman I, Heremans Y, Heimberg H, Bouwens L . Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro. Diabetologia 2000; 43: 907–914.

    Article  CAS  Google Scholar 

  24. Rooman I, Lardon J, Flamez D, Schuit F, Bouwens L . Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas. Gastroenterology 2001; 121: 940–949.

    Article  CAS  Google Scholar 

  25. Rooman I, Bouwens L . Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycemia in C57BL/6J mice treated with alloxan. Diabetologia 2004; 47: 259–265.

    Article  CAS  Google Scholar 

  26. Fujita Y, Cheung AT, Kieffer TJ . Harnessing the gut to treat diabetes. Pediatr Diabetes 2004; 5 (Suppl 2): 57–59.

    Article  Google Scholar 

  27. Kaneto H, Matsuoka T, Nakatani Y, Miyatsuka T, Matsuhisa M, Hori M et al. A crucial role of MafA as a novel therapeutic target for diabetes. J Biol Chem 2005; 280: 15047–15052.

    Article  CAS  Google Scholar 

  28. Chen SY, Shohet RV, Bekeredjian R, Frenkel PA, Grayburn PA . Optimization of ultrasound parameters for cardiac gene delivery of adenoviral and plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003; 42: 301–308.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by NIH grant P01 DK58398, and the Mark Shepherd Research Fund of the Baylor Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P A Grayburn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, S., Ding, J., Yu, C. et al. Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1. Gene Ther 14, 1102–1110 (2007). https://doi.org/10.1038/sj.gt.3302963

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302963

Keywords

This article is cited by

Search

Quick links